Predicting cancer return after robotic prostate surgery
Part of Cancer, Kidney & urinary clinical trials.
This study looks at men with early-stage prostate cancer who had robotic surgery to remove the prostate. It aims to find which factors predict if the cancer might come back, helping doctors plan better follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer that has not spread beyond the prostate.
- You had surgery to remove your prostate using a robotic-assisted technique.
- You are 18 years or older.
- You have not had hormone therapy, radiation, or chemotherapy before your surgery.
- You do not have another active cancer (other than non-melanoma skin cancer).
- You have had at least one PSA blood test after surgery to check for cancer recurrence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This study is testing a special recovery plan that helps men heal faster after robot-assisted prostate cancer surgery. If you are eligible, you may benefit from a structured exercise and recovery program.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.